膽管癌市場規模、佔有率及成長分析（按適應症、治療、最終用戶、地區和細分市場預測），2025 年至 2032 年

2023 年全球膽管癌市場規模價值為 36 億美元，預計將從 2024 年的 39.1 億美元成長到 2032 年的 75 億美元，預測期間（2025-2032 年）的複合年成長率為 8.5%。

由於發病率上升、技術進步和研發增加，膽管癌市場正在經歷顯著成長。美國每年約有 8,000 人被診斷出患有膽管癌，發病率呈上升趨勢，尤其是在老年人口和受肝流感和肝炎影響的地區。 PET-CT 和 MRI 等影像技術的創新正在增強早期檢測和治療計劃，紀念斯隆凱特琳癌症中心等機構使用先進技術就是一個例證。此外，艾倫·莫雷門特紀念基金等日益增強的宣傳活動強調了研究病因和治療方法的重要性。然而，挑戰依然存在，包括晚期治療選擇有限、治療費用高以及早期診斷困難，尤其是在低收入國家。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 定價分析
• 案例研究分析
• 技術分析
• 臨床試驗分析
• FDA核准的藥物分析
• 監管分析

膽管癌市場規模（依適應症）

• 市場概覽
• 肝外膽管癌
  • 肝門部膽管癌
  • 遠端膽管癌
• 肝內膽管癌

膽管癌治療市場規模

• 市場概覽
• 外科手術
  • 腹腔鏡檢查
  • 膽道旁路
  • 支架置入
  • 其他
• 放射治療
  • 體外放射線治療（EBRT）
  • 體內放射療法
• 化療
• 標靶藥物治療
  • FGFR2抑制劑
  • IDH1抑制劑
  • TRK抑制劑
  • 其他
• 免疫療法
• 安寧療護

膽管癌市場規模（依最終用戶）

• 市場概覽
• 醫院和診所
• 癌症診所
• 其他

膽管癌市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Memorial Sloan Kettering Cancer Center（MSK）
• The University of Texas MD Anderson Cancer Center
• City of Hope
• Mass General Brigham Incorporated
• Scripps Health
• Moffitt
• Cleveland Clinic
• Winship Cancer Institute of Emory University
• penn Medicine（Abramson Cancer Center）
• University Hospitals
• Kokilaben Dhirubhai Ambani Hospital
• Apollo Hospitals
• BLK-Max Super Speciality Hospital
• Max Healthcare
• Mayo Clinic
• Dana-Farber Cancer Institute
• Johns Hopkins Hospital
• Mount Sinai Hospital
• UCSF Health-UCSF Medical Center
• UCLA Medical Center

結論和建議

Global Bile Duct Cancer Market size was valued at USD 3.6 billion in 2023 and is poised to grow from USD 3.91 billion in 2024 to USD 7.5 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

The bile duct cancer market is experiencing substantial growth driven by rising incidence rates, technological advancements, and increased research and development. Each year, approximately 8,000 individuals in the U.S. are diagnosed with cholangiocarcinoma, with prevalence rising, particularly among aging populations and regions affected by liver fluke infections and hepatitis. Innovations in diagnostic imaging, including PET-CT and MRI, enhance early detection and treatment planning, exemplified by the use of advanced techniques at institutions like Memorial Sloan Kettering Cancer Center. Additionally, growing awareness initiatives, such as those by the Alan Morement Memorial Fund, highlight the importance of research into causes and treatments. However, challenges remain, including limited late-stage therapies, high treatment costs, and difficulties in early diagnosis, particularly in lower-income countries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bile Duct Cancer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bile Duct Cancer Market Segments Analysis

Global Bile Duct Cancer Market is segmented by Indication, By Treatment, By End User and region. Based on By Indication, the market is segmented into Extrahepatic Bile Duct Cancer and Intrahepatic Bile Duct Cancer. Based on By Treatment, the market is segmented into Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy, Immunotherapy and Palliative Therapy. Based on By End User, the market is segmented into Hospital & Clinics, Cancer Specialty Clinic and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bile Duct Cancer Market

The global bile duct cancer market is experiencing robust growth driven by the increasing incidence of bile duct cancer and the expanding elderly population. Older adults are particularly susceptible to cancer due to a compromised immune system and extended exposure to risk factors, including chronic liver disease and liver infections. As a result, the projected statistics indicate a significant rise in cancer cases and fatalities among senior demographics, with anticipated figures of approximately 20.7 million new cases and 12.7 million deaths by 2040. This escalating prevalence underscores the urgent need for advancements in treatment and care strategies within the market.

Restraints in the Global Bile Duct Cancer Market

The Global Bile Duct Cancer market faces significant restraints due to the severe side effects associated with various cancer treatments, hindering patient adherence and overall market growth. Standard treatment options, including chemotherapy, targeted drug therapy, and radiation therapy, commonly lead to adverse effects that drastically impact patients' quality of life. These side effects often include hair loss, fatigue, nausea, and neutropenia. Additionally, the apprehension regarding treatment-related toxicity affects patients' decisions regarding their treatment options and their readiness to participate in clinical trials, ultimately impeding the advancement of new therapeutic innovations in the market.

Market Trends of the Global Bile Duct Cancer Market

In the short term, the Global Bile Duct Cancer market is poised for significant growth, propelled by heightened awareness around early diagnosis and the demand for personalized treatment solutions. Innovations in diagnostic technologies, including molecular profiling and AI-assisted imaging, are set to improve treatment accuracy and efficiency. Moreover, the rising emphasis on precision medicine, coupled with the development of targeted therapies, is enhancing treatment options, enabling healthcare providers to offer bespoke therapeutic strategies that cater to individual patient profiles. As a result, these trends are collectively driving market expansion and fostering a positive outlook for the bile duct cancer sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Pricing Analysis
• Case Study Analysis
• Technology Analysis
• Clinical Trial Analysis
• Fda Approval Drug Analysis
• Regulatory Analysis

Global Bile Duct Cancer Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Extrahepatic Bile Duct Cancer
  • Hilar Bile Duct Cancer
  • Distal Bile Duct Cancer
• Intrahepatic Bile Duct Cancer

Global Bile Duct Cancer Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Surgery
  • Laparoscopy
  • Biliary bypass
  • Stent placement
  • Others
• Radiation Therapy
  • External beam radiation therapy (EBRT)
  • Internal radiation therapy
• Chemotherapy
• Targeted Drug Therapy
  • FGFR2 Inhibitors
  • IDH1 Inhibitor
  • TRK Inhibitors
  • Others
• Immunotherapy
• Palliative Therapy

Global Bile Duct Cancer Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital & Clinics
• Cancer Specialty Clinic
• Others

Global Bile Duct Cancer Market Size & CAGR (2025-2032)

• North America (By Indication, By Treatment, By End User)
  • US
  • Canada
• Europe (By Indication, By Treatment, By End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Indication, By Treatment, By End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Indication, By Treatment, By End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Indication, By Treatment, By End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Memorial Sloan Kettering Cancer Center (MSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The University of Texas MD Anderson Cancer Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• City of Hope
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mass General Brigham Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scripps Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moffitt
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland Clinic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Winship Cancer Institute of Emory University
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• penn Medicine (Abramson Cancer Center)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• University Hospitals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kokilaben Dhirubhai Ambani Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apollo Hospitals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BLK-Max Super Speciality Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Max Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayo Clinic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dana-Farber Cancer Institute
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johns Hopkins Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mount Sinai Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCSF Health-UCSF Medical Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCLA Medical Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations